Dear Sir, Please find the attached intimation under Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted a regulatory compliance filing to BSE and MSEI under SEBI LODR Regulation 57(5). The company confirmed that it has not issued any non-convertible securities (NCS). As a result, there were no interest, dividend, or principal payment obligations due during the quarter from January 1, 2025 to March 31, 2025. The intimation was signed by Director Davender Singh (DIN: 09447213). This is a routine quarterly compliance confirmation with no financial events to disclose.
No material impact on shareholders or stock price. This is a routine regulatory compliance confirmation indicating the company has no non-convertible securities outstanding, so there is nothing actionable for investors.